Skip to main content

Please wait ...

Anne Wagner, PhD, C Psych


Anne Wagner, PhD, CPsych, Adjunct Professor, Department of Psychology & Associate Member, Yeates School of Graduate Studies at Ryerson University, Toronto. Trainer in CBCT and CPT. Team member, MDMA trial for Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD. Founder of Remedy (www.remedycentre.ca), a centre for mental health innovation.

Speaker Disclosures:
Financial: Anne Wagner is the founder of Remedy and Remedy Institute. She has employment relationships with Toronto Metropolitan University, Maya Atlas, and Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation. She receives compensation as a trainer, collaborator, and consultant. She receives grants from Philanthropic Donors and the Australian National Health and Medical Research Council Innovative. Anne Wagner is a consultant with Lykos Therapeutics. She receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Anne Wagner is a member of the Canadian Psychological Association, the International Society of Traumatic Stress Studies, and Association for Behavioral and Cognitive Therapies. She is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress


Credit available - Click Here for more information

Speakers:
Michael Mithoefer, MD |  Rick Doblin, PhD |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, PhD |  Anne Wagner, PhD, C Psych |  ....
Duration:
3 Hours 59 Minutes
Copyright:
May 18, 2021
Product Code:
POS052719
Media Type:
Digital Seminar
Price:
$129.99 - 50% off - Black Friday CE Deal Normal Price: Standard - $259.99

Showing 1 to 2 of 2 entries